SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-058165
Filing Date
2023-11-02
Accepted
2023-11-02 16:05:47
Documents
63
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sndx-20230930.htm   iXBRL 10-Q 2376294
2 EX-31.1 sndx-ex31_1.htm EX-31.1 14878
3 EX-31.2 sndx-ex31_2.htm EX-31.2 15237
4 EX-32.1 sndx-ex32_1.htm EX-32.1 14820
  Complete submission text file 0000950170-23-058165.txt   9724340

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sndx-20230930_def.xml EX-101.DEF 196347
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sndx-20230930_cal.xml EX-101.CAL 45861
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sndx-20230930_lab.xml EX-101.LAB 406763
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sndx-20230930_pre.xml EX-101.PRE 308465
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sndx-20230930.xsd EX-101.SCH 55255
57 EXTRACTED XBRL INSTANCE DOCUMENT sndx-20230930_htm.xml XML 2273352
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 231372208
SIC: 2834 Pharmaceutical Preparations